Literature DB >> 7977280

Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction.

M Wei1, C A Macera, D R Davis, C A Hornung, H R Nankin, S N Blair.   

Abstract

Although erectile dysfunction is frequently seen in patients with manifestations of arteriosclerotic disease, the independent contribution of serum cholesterol in predicting erectile dysfunction is unclear. The aim of this study was to examine the relation between serum cholesterol and erectile dysfunction. Medical histories, physical examinations, and blood tests were obtained at Cooper Clinic, Dallas, Texas, from 3,250 men aged 26-83 years (mean, 51 years) without erectile dysfunction at their first visit, who had one more clinic visit, all between 1987 and 1991. These men were followed 6-48 months after the first clinic visit (mean, 22 months). Erectile dysfunction was reported in 71 men (2.2%) during follow-up. Every mmol/liter of increase in total cholesterol was associated with 1.32 times the risk of erectile dysfunction (95% confidence interval 1.04-1.68), while every mmol/liter of increase in high density lipoprotein cholesterol was associated with 0.38 times the risk (95% confidence interval 0.18-0.80). Men with a high density lipoprotein cholesterol measurement over 1.55 mmol/liter (60 mg/dl) had 0.30 times the risk (95% confidence interval 0.09-1.03) as did men with less than 0.78 mmol/liter (30 mg/dl). Men with total cholesterol over 6.21 mmol/liter (240 mg/dl) had 1.83 times the risk (95% confidence interval 1.00-3.37) as did men with less than 4.65 mmol/liter (180 mg/dl). Those differences remained essentially unchanged after adjustment for other potential confounders. The authors conclude that a high level of total cholesterol and a low level of high density lipoprotein cholesterol are important risk factors for erectile dysfunction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977280     DOI: 10.1093/oxfordjournals.aje.a117181

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  31 in total

Review 1.  Erectile dysfunction and atherosclerosis.

Authors:  Robert A Kloner; Mark Speakman
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

Review 2.  Common conditions of the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression.

Authors:  L Zakaria; A G Anastasiadis; R Shabsigh
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 3.  Mesenchymal stem cell-based gene therapy for erectile dysfunction.

Authors:  J H Kim; H J Lee; Y S Song
Journal:  Int J Impot Res       Date:  2016-02-18       Impact factor: 2.896

4.  Association between smoking, passive smoking, and erectile dysfunction: results from the Boston Area Community Health (BACH) Survey.

Authors:  Varant Kupelian; Carol L Link; John B McKinlay
Journal:  Eur Urol       Date:  2007-03-16       Impact factor: 20.096

Review 5.  Prevalence of sexual dysfunctions: results from a decade of research.

Authors:  J S Simons; M P Carey
Journal:  Arch Sex Behav       Date:  2001-04

6.  Is apolipoprotein-(a) an important indicator of vasculogenic erectile dysfunction?

Authors:  O Atahan; O Kayigil; N Hizel; A Metin
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

7.  TNF-alpha knockout mice have increased corpora cavernosa relaxation.

Authors:  Fernando S Carneiro; Lashon C Sturgis; Fernanda R C Giachini; Zidonia N Carneiro; Victor V Lima; Brandi M Wynne; Sebastian San Martin; Michael W Brands; Rita C Tostes; R Clinton Webb
Journal:  J Sex Med       Date:  2009-01       Impact factor: 3.802

8.  Relative contributions of modifiable risk factors to erectile dysfunction: results from the Boston Area Community Health (BACH) Survey.

Authors:  Varant Kupelian; Andre B Araujo; Gretchen R Chiu; Raymond C Rosen; John B McKinlay
Journal:  Prev Med       Date:  2009-11-24       Impact factor: 4.018

9.  History, mystery and chemistry of eroticism: Emphasis on sexual health and dysfunction.

Authors:  M R Asha; G Hithamani; R Rashmi; K H Basavaraj; K S Jagannath Rao; T S Sathyanarayana Rao
Journal:  Indian J Psychiatry       Date:  2009-04       Impact factor: 1.759

Review 10.  Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence.

Authors:  Antonio Martín Morales; Vincenzo Mirone; John Dean; Pierre Costa
Journal:  Clin Interv Aging       Date:  2009-12-29       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.